Immunization, Hib3 in Palau
Palau: Immunization, Hib3 was 99.0% in 2024. ▬ Flat
Immunization, Hib3 in Palau, 1998–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
Palau recorded 99.0% for immunization, hib3 in 2024. That is the highest value across all 27 years on record.
The figure is up 7.6% on the previous year and unchanged over ten years.
Over the whole period, immunization, hib3 in Palau peaked at 99.0% in 2013 and was at its lowest, 48.0%, in 2009.
That places Palau 1st out of 191 countries with data for 2024, putting it in the top 10%.
Immunization, Hib3 in Palau, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1998 | 74.0% | — |
| 1999 | 96.0% | +29.7% |
| 2000 | 96.0% | +0.0% |
| 2001 | 93.0% | -3.1% |
| 2002 | 90.0% | -3.2% |
| 2003 | 94.0% | +4.4% |
| 2004 | 98.0% | +4.3% |
| 2005 | 98.0% | +0.0% |
| 2006 | 98.0% | +0.0% |
| 2007 | 95.0% | -3.1% |
| 2008 | 92.0% | -3.2% |
| 2009 | 48.0% | -47.8% |
| 2010 | 66.0% | +37.5% |
| 2011 | 85.0% | +28.8% |
| 2012 | 89.0% | +4.7% |
| 2013 | 99.0% | +11.2% |
| 2014 | 99.0% | +0.0% |
| 2015 | 89.0% | -10.1% |
| 2016 | 98.0% | +10.1% |
| 2017 | 95.0% | -3.1% |
| 2018 | 92.0% | -3.2% |
| 2019 | 93.0% | +1.1% |
| 2020 | 89.0% | -4.3% |
| 2021 | 89.0% | +0.0% |
| 2022 | 86.0% | -3.4% |
| 2023 | 92.0% | +7.0% |
| 2024 | 99.0% | +7.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 85.0% | 74.0% | 96.0% | 2 |
| 2000s | 90.2% | 48.0% | 98.0% | 10 |
| 2010s | 90.5% | 66.0% | 99.0% | 10 |
| 2020s | 91.0% | 86.0% | 99.0% | 5 |
Countries ranked near Palau
- 1 Antigua and Barbuda 99.0% compare
- 1 Brunei Darussalam 99.0% compare
- 1 Costa Rica 99.0% compare
- 1 Cuba 99.0% compare
- 1 Greece 99.0% compare
- 1 Hungary 99.0% compare
- 1 Jamaica 99.0% compare
- 1 Korea, Democratic People's Republic of 99.0% compare
- 1 Kuwait 99.0% compare
- 1 Luxembourg 99.0% compare
- 1 Maldives 99.0% compare
- 1 Monaco 99.0% compare
- 1 Oman 99.0% compare
- 1 Portugal 99.0% compare
- 1 Saint Lucia 99.0% compare
- 1 Saint Vincent and the Grenadines 99.0% compare
- 1 Tonga 99.0% compare
- 1 Türkiye 99.0% compare
More health data for Palau
- Estimated changes in temperature-related death rates compared to projected death rates 1,529 deaths per 1,000 people (2090)
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2087)
- Heat deaths vs projected death rates, annual growth rate 0.2689 % change on previous year (2090)
- Number of infants who die before age 1 0 deaths (2100)
- Age population, age 09, male, interpolated 117 (2025)
- Population, male 9,506 (2025)
- Age population, age 09, female, interpolated 103 (2025)
- Age population, age 08, male, interpolated 112 (2025)
- Age population, age 08, female, interpolated 101 (2025)
- Age population, age 07, male, interpolated 106 (2025)
Frequently asked questions
- What is immunization, hib3 in Palau?
- Immunization, hib3 in Palau was 99.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Palau?
- The highest recorded value was 99.0% in 2013.
- What is the lowest immunization, hib3 recorded in Palau?
- The lowest recorded value was 48.0% in 2009.
- How does Palau rank for immunization, hib3?
- Palau ranks 1st out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Palau?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Palau data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 27 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.